
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.120 | 3.150 | 1.030 |
Shares | 99.190 | 100.180 | 0.990 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.022 | 19.606 |
Price to Book | 3.425 | 3.867 |
Price to Sales | 1.676 | 2.210 |
Price to Cash Flow | 13.703 | 14.698 |
Dividend Yield | 0.384 | 1.499 |
5 Years Earnings Growth | 13.709 | 9.831 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 93.390 | 95.058 |
Technology | 5.040 | 3.340 |
Consumer Defensive | 0.960 | 3.093 |
Industrials | 0.620 | 2.625 |
Basic Materials | -0.010 | 1.756 |
Number of long holdings: 145
Number of short holdings: 23
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Invesco NASDAQ Biotech | IE00BQ70R696 | 5.86 | 48.50 | -0.74% | |
Motif Bio PLC | GB00BVVT4H71 | 3.18 | - | - | |
Teladoc Health Inc | - | 2.54 | - | - | |
Eurofins Scientific SE | FR0000038259 | 2.13 | - | - | |
Fagron | BE0003874915 | 2.12 | 20.75 | -0.24% | |
Express Scripts Holding Co | - | 1.91 | - | - | |
Biomarin Pharmaceutical Inc | - | 1.86 | - | - | |
CytoSorbents Corp | - | 1.85 | - | - | |
Hologic Inc | - | 1.75 | - | - | |
Nevro Corp | - | 1.72 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI A | 6.31B | 0.05 | 4.35 | 5.76 | ||
Acatis Gane Value Event Fonds UI B | 6.31B | 0.31 | 4.79 | 6.21 | ||
Acatis Gane Value Event Fonds UI C | 6.31B | 0.05 | 4.34 | 5.62 | ||
ACATIS Datini Valueflex Fonds A | 791.4M | 7.84 | 6.15 | 11.62 | ||
ACATIS Datini Valueflex Fonds B | 791.4M | 7.33 | 5.27 | 10.80 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review